RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (FRX:CA), a commercial stage specialty pharmaceutical company, today announced that the U.S. Food and Drug ...
The US Food and Drug Administration (FDA) has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals) injection to reduce the risk for ototoxicity associated with cisplatin in pediatric patients ...
Detailed price information for Shanghai Fosun Pharm Reg (SFOSF) from The Globe and Mail including charting and trades.
~ PEDMARK is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-metastatic Solid Tumors ~ ~ The ...
RESEARCH TRIANGLE PARK, N.C., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced the U.S.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement with Cipla Limited and Cipla USA, Inc. to settle the ...
RESEARCH TRIANGLE PARK, N.C., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the U.S.
SCOTTSDALE, Ariz., June 05, 2018 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced enrollment of the first Canadian subject to participate in the CALISTA clinical study that is evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results